LIVE
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfiz. Track Pfizer Limited's live NSE:PFIZER share price ₹4,899.00 (+1.56%), market cap ₹₹224B, P/E 30.5. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for PFIZER — real-time NSE India stock intelligence.
Open
₹4,823.90
High
₹4,904.00
Low
₹4,804.90
Prev. Close
₹4,823.90
52W High
₹5,873.50
52W Low
₹4,360.10
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfiz
Key Takeaway
Pfizer Limited is rated strong buy with a P/E of 30.5x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is Pfizer Limited fairly valued right now?
Because a P/E of 30.5x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Pfizer Limited
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
653 Cr
Revenue
204 Cr
Net Profit
0%
ROE
0%
ROCE
160.64
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 2,422 | 2,193 | 2,281 | 2,519 | 2,569 |
| Net Profit | 624 | 551 | 768 | 722 | 735 |
| ROE (%) | — | — | — | 0.0% | 0.0% |
| EPS (₹) | — | — | — | 160.64 | 160.64 |
| Debt/Equity | — | — | — | 1.7 | 1.7 |